Newsletter
Newsletter Support JNS

Former Israeli prime minister Barak appointed chair of medical marijuana company

In a statement, InterCure said Ehud Barak’s “stature” will be helpful for the company’s development.

Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.
Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

Former Israeli Prime Minister Ehud Barak will chair the Israeli medical marijuana company InterCure, according to the firm, which made the announcement on Wednesday.

Barak served as defense minister and then prime minister in the early 2000s. He has remained in the public spotlight since leaving politics, usually criticizing current government policies.

InterCure said that Barak will head its global growth initiative. In a statement, the company said Barak’s “stature” will be helpful for the company’s development.

Barak will work 40 monthly hours for $10,000 per month. He will also be eligible for stock options, according to the company.

InterCure, publicly traded in Israel, is expected to change its name to Canndoc Pharma.

“We now have full cooperation with Israel, and hopefully they will encourage Jewish or Israeli investment in Somaliland,” the president of the breakaway republic told reporters.
The Israeli prime minister plans to address the General Assembly on “Iran, the Abraham Accords and opportunities in the region,” the Israeli envoy to the global body told JNS.
“Canada’s government will do everything in our power to support law enforcement in ensuring that the perpetrator is held accountable,” said Premier Mark Carney.
Qatari liquefied natural gas exports plunged 96% amid fallout from Iranian strikes on its energy sites.